Finland· FI-REL-REL24106
Tobrasone
A dexamethason mit antiinfektiva product containing tobramycin + dexamethasone, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Tobramycin + Dexamethasone
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason mit antiinfektiva in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTobraDexNovartis Pharmaceuticals Corporation
- PolandBrazoflaminSynoptis Pharma Sp. z o.o.
- United KingdomDexamethasone 0.1% / Tobramycin 0.3% eye dropsAlliance Healthcare (Distribution) Ltd
- NetherlandsBradexa 3 mg/ml + 1 mg/ml oogdruppels, suspensieRockmed Pharma B.V.
- FranceTOBRADEX, collyre en suspensionNOVARTIS PHARMA
- CanadaTOBRADEXNOVARTIS PHARMACEUTICALS CANADA INC
- SwitzerlandTobradex, AugensalbeNovartis Pharma Schweiz AG
- NorwayTobrasoneNOVARTIS NORGE AS
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Tobradex
- Belgium · Tobradex
- Bulgaria · Декс-Тобрин, Медетром
- Cyprus · Lofoto, Tobradex
- Czechia · Tobradex
- Germany · Tobradex
- Denmark · Oridecin, Tobradex
- Estonia · Tobradex, Tobramycin/Dexamethasone Elvim
- Spain · Tobradex
- France · Tobradex, Todexal
- United Kingdom (Northern Ireland) · Tobradex, Tobramycin + Dexamethasone Blumont Pharma
- Greece · Lofoto, O-Biotic
- Croatia · Tobradex
- Hungary · Tobradex, Todep
- Iceland · Tobradex
- Italy · Iridina Infezioni E Infiammazioni, Luxabiotic
- Lithuania · Tobradex, Tobramycin/Dexamethasone Elvim
- Luxembourg · Tobradex
- Latvia · Tobradex, Tobramycin/Dexamethasone Elvim
- Malta · Tobradex
- Netherlands · Bradexa, Tobradex
- Norway · Tobrasone, Toflacort
- Poland · Brazoflamin, Mybracin
- Portugal · Dextob, Tobradex
- Romania · Dexatobrom, Tobradex
- Sweden · Tobrasone, Toflacort
- Slovenia · Tobradex
- Slovakia · Tobradex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8f61662-04a2-41aa-a1d1-62217341748a GET /v1/drugs/f8f61662-04a2-41aa-a1d1-62217341748a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, suspensio",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "3 mg/ml + 1 mg/ml",
"atc_label": "deksametasoni ja mikrobilääkkeet",
"ma_number": "21022",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL24106",
"authorised_at": "2006-01-17"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.